Español
|
English
BUSCADOR
CIBER
INTRANET
LINKS
WEBMAIL
Toggle navigation
MENÚ
About us
Welcome from the Director
Mission and Objectives
Structure
Steering Committee
External Scientific Advisory Committee (ESAC)
Patients Advisory Council
Governing Board
Permanent Commission
Consortium Institutions
Head Office
Scientific Management
Thematic Areas
Information Resources
Contact
Groups
Research Groups
Clinical Linked Groups
Geographical Distribution
Research Programmes
Translational Genomic Medicine Programme
Mitochondrial Medicine and Inherited Metabolic Programme
Neurological Disorders Programme
Paediatric and Developmental Medicine Programme
Sensorineural Pathology Programme
Endocrine Medicine Programme
Inherited Cancer, Haematologic and Dermatological Diseases Programme
Transversal Programmes
Scientific projects
Cooperative and Complementary Intramural Actions
Translational Research Projects in cooperation with linked clinical groups
Undiagnosed Rare Diseases Programme (ENoD)
CIBERER Spanish Variant Server
SPANEX Project
Human Resources Programme
Training Programme
Knowledge Application Programme
Internationalization Programme
Science dissemination programme
Platforms
CIBERER Biobank
ORPHANET
BIER
CIBERER Spanish Variant Server
MAPER
Press
Events
CIBER Newsletter
CIBERER Newsletter
CIBERER Social Newsletter
Sala de Prensa
Agenda
Medicamentos huérfanos y distrofias de la retina: Situación actual
Medicamentos huérfanos y distrofias de la retina: Situación actual
Thursday, February 20, 2020
Lugar:
Aula Severo Ochoa, IIS-Fundación Jiménez Díaz. Madrid.
Programa
Back to List
